Erika Cheung Questions Austin AI Startup CEO
The former Theranos employee expressed concern over Billy Evans’ startup and his ties to Elizabeth Holmes.
Updated on Oct. 26, 2026 in Startups

Live Poll
Should individuals convicted of corporate fraud be trusted if they launch new businesses after prison?
Erika Cheung, who previously worked at Theranos, has voiced concerns regarding Haemanthus, an AI diagnostic startup based in Austin led by Billy Evans. Evans is the partner of Elizabeth Holmes, the former Theranos executive convicted of defrauding investors in 2022.
Why it matters
Cheung publicly questioned the startup because she believes Holmes, who remains incarcerated, has not accepted accountability for her past actions. Concerns persist regarding the influence of Holmes on Evans, despite official denials of her involvement in the new firm.
Elizabeth Holmes is serving a reduced prison sentence of 10 years and 3 months. She and partner Billy Evans are the parents of two children.
The players
Erika Cheung
She is a former employee of Theranos who became a vocal whistleblower regarding the company's fraudulent practices.
Billy Evans
He is the CEO of the Austin-based diagnostic startup Haemanthus and the partner of Elizabeth Holmes.
Elizabeth Holmes
She is the founder of the defunct company Theranos who was convicted of fraud after misleading investors about her blood-testing technology.
Haemanthus
This is an AI diagnostic startup headquartered in Austin, Texas.
The details
Haemanthus, an Austin-based diagnostic startup, explicitly stated on X that Elizabeth Holmes has zero involvement in the company. Reports from May 2025 previously alleged that Holmes was advising Evans on his business activities while she remained in prison.
Timeline
Elizabeth Holmes was convicted of defrauding investors in 2022.
Reports regarding Holmes advising Evans from prison emerged in May 2025.
Holmes is scheduled to move to an Austin halfway house on August 23, 2027.
The scheduled release date for Holmes from prison is February 22, 2030.
Market Landscape
This scrutiny of Haemanthus follows a pattern of intense skepticism regarding the return of industry figures linked to the Theranos fraud case. The situation reflects how historical corporate failures continue to influence the startup landscape in Austin.
Local investors and residents may monitor Haemanthus more closely due to its leadership's proximity to a high-profile corporate fraud case. The company's public assertion of non-involvement by Holmes serves as a pragmatic attempt to maintain brand legitimacy.
The takeaway
Transparency remains a critical factor for new startups seeking to establish credibility in the healthcare sector. Entrepreneurs with associations to past controversies often face heightened public scrutiny regarding their management and strategic independence.
What happens next
Elizabeth Holmes is scheduled to transition to an Austin halfway house on August 23, 2027, followed by her full release from prison on February 22, 2030.
Further reading
For more on the local tech ecosystem, visit the Austin Startups section.
Source note: This article includes information reported by NewsNation.
Live Poll
Should individuals convicted of corporate fraud be trusted if they launch new businesses after prison?










